Parkinson's disease occurs when brain cells that produce an important hormone called dopamine begin to die off or become ...

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

A recent phase 2 clinical trial reveals that Ambroxol, a common cough medicine, shows promise in stabilizing psychiatric ...

Parkinson's may be due to environmental causes. One million people have the neurodegenerative disease that robs them of their ...

Groundbreaking new research released from Northwestern Medicine discovered that a usually harmless virus in the blood, may be ...

A new study reveals that which side of the body is initially affected by Parkinson's disease can predict cognitive decline ...

People with Parkinson’s often stay silent about their diagnosis. Here’s what drives that silence and why understanding it ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Researchers in Chicago believe they’ve found a virus that could be a trigger for Parkinson’s disease. Parkinson’s impacts ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...